[Revascularization in patients with type 2 diabetes and coronary artery disease: BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) Study Group]

Internist (Berl). 2010 May;51(5):674-6. doi: 10.1007/s00108-010-2593-6.
[Article in German]
No abstract available

Publication types

  • Comment

MeSH terms

  • Angioplasty, Balloon, Coronary
  • Combined Modality Therapy
  • Coronary Angiography
  • Coronary Artery Bypass
  • Coronary Disease / complications
  • Coronary Disease / surgery
  • Coronary Disease / therapy*
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Female
  • Glycated Hemoglobin
  • Humans
  • Hypoglycemic Agents / adverse effects
  • Hypoglycemic Agents / therapeutic use*
  • Insulin / adverse effects
  • Insulin / therapeutic use*
  • Kaplan-Meier Estimate
  • Male
  • Metformin / therapeutic use
  • Middle Aged
  • Myocardial Infarction / epidemiology
  • Myocardial Infarction / prevention & control
  • Stroke / epidemiology
  • Stroke / prevention & control
  • Sulfonylurea Compounds / therapeutic use
  • Thiazolidinediones / therapeutic use

Substances

  • Glycated Hemoglobin A
  • Hypoglycemic Agents
  • Insulin
  • Sulfonylurea Compounds
  • Thiazolidinediones
  • Metformin
  • 2,4-thiazolidinedione